{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:55:45Z","timestamp":1790081745035,"version":"4.0.1"},"reference-count":165,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Diabetic cardiomyopathy (DbCM) is a common complication in individuals with type 2 diabetes mellitus (T2DM), and its exact pathogenesis is still debated. It was hypothesized that chronic hyperglycemia and insulin resistance activate critical cellular pathways that are responsible for numerous functional and anatomical perturbations in the heart. Interstitial inflammation, oxidative stress, myocardial apoptosis, mitochondria dysfunction, defective cardiac metabolism, cardiac remodeling, hypertrophy and fibrosis with consequent impaired contractility are the most common mechanisms implicated. Epigenetic changes also have an emerging role in the regulation of these crucial pathways. The aim of this review was to highlight the increasing knowledge on the molecular mechanisms of DbCM and the new therapies targeting specific pathways.<\/jats:p>","DOI":"10.3390\/ijms25158280","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:08:34Z","timestamp":1722359314000},"page":"8280","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Molecular Basis of Cardiomyopathies in Type 2 Diabetes"],"prefix":"10.3390","volume":"25","author":[{"given":"Silvia","family":"Giardinelli","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Pediatrics, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9924-4915","authenticated-orcid":false,"given":"Giovanni","family":"Meliota","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Giovanni XXIII Pediatric Hospital, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0680-5251","authenticated-orcid":false,"given":"Donatella","family":"Mentino","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"D\u2019Amato","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Di Venere Hospital, 70012 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1899-8337","authenticated-orcid":false,"given":"Maria Felicia","family":"Faienza","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"ref_1","unstructured":"Goyal, R., Singhal, M., and Jialal, I. (2024). Type 2 Diabetes. StatPearls, StatPearls Publishing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1606491","DOI":"10.3389\/ijph.2023.1606491","article-title":"The Burden of Type 1 and Type 2 Diabetes among Adolescents and Young Adults in 24 Western European Countries, 1990\u20132019: Results from the Global Burden of Disease Study 2019","volume":"68","author":"Armocida","year":"2024","journal-title":"Int. J. Public Health"},{"key":"ref_3","first-page":"220","article-title":"Pathophysiology of Type 2 Diabetes in Children and Adolescents","volume":"16","author":"Valaiyapathi","year":"2020","journal-title":"Curr. Diabetes Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Pastore, I., Bolla, A.M., Montefusco, L., Lunati, M.E., Rossi, A., Assi, E., Zuccotti, G.V., and Fiorina, P. (2020). The impact of diabetes mellitus on cardiovascular risk onset in children and adolescents. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144928"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijcard.2014.04.115","article-title":"Insulin resistance and endothelial function in children and adolescents","volume":"174","author":"Miniello","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1253\/circj.CJ-15-1038","article-title":"Vascular Function and Myocardial Performance Indices in Children Born Small for Gestational Age","volume":"80","author":"Faienza","year":"2016","journal-title":"Circ. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.18632\/aging.202624","article-title":"Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: A biopsy-based study","volume":"13","author":"Wu","year":"2021","journal-title":"Aging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-020-05319-w","article-title":"Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: Systematic review and meta-analyses","volume":"64","author":"Nanayakkara","year":"2021","journal-title":"Diabetologia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"46534","DOI":"10.1038\/srep46534","article-title":"The characteristics of newly diagnosed adult early-onset diabetes: A population-based cross-sectional study","volume":"7","author":"Zou","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e030683","DOI":"10.1161\/JAHA.123.030683","article-title":"Association between Age at Diagnosis of Type 2 Diabetes and Hospitalization for Heart Failure: A Population-Based Study","volume":"13","author":"Ke","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lindberg, L., Danielsson, P., Persson, M., Marcus, C., and Hagman, E. (2020). Association of childhood obesity with risk of early all-cause and cause-specific mortality: A Swedish prospective cohort study. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003078"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Swiatkiewicz, I., Patel, N.T., Villarreal-Gonzalez, M., and Taub, P.R. (2024). Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center. BMC Med., 22.","DOI":"10.1186\/s12916-024-03401-3"},{"key":"ref_14","unstructured":"NHS Digital (2019, December 13). National Diabetes Audit, 2017\u20132018. Available online: https:\/\/files.digital.nhs.uk\/91\/084B1D\/National%20Diabetes%20Audit%2C%202017-18%2C%20Report%202a.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41420-023-01553-4","article-title":"Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions","volume":"9","author":"Huo","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sudo, S.Z., Montagnoli, T.L., Rocha, B.D.S., Santos, A.D., de S\u00e1, M.P., and Zapata-Sudo, G. (2022). Diabetes-induced cardiac autonomic neuropathy: Impact on heart function and prognosis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123258"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"20420188221083530","DOI":"10.1177\/20420188221083530","article-title":"Role of inflammation in diabetic cardiomyopathy","volume":"13","author":"Ramesh","year":"2022","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvx011","article-title":"An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy","volume":"113","author":"Frati","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1210\/en.2006-0728","article-title":"Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes","volume":"147","author":"Aragno","year":"2006","journal-title":"Endocrinology"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wang, N., Liang, H., and Zen, K. (2014). Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00614"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zeng, C., Wang, R., and Tan, H. (2019). Role of pyroptosis in cardiovascular diseases and its therapeutic implications. Int. J. Biol. Sci., 15.","DOI":"10.7150\/ijbs.33568"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00394-021-02768-w","article-title":"Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL\/6 mice and AC16 cells","volume":"61","author":"Qu","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., and An, F. (2014). NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104771"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.yjmcc.2010.12.022","article-title":"Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia\u2013reperfusion injury: A predominant role of anti-inflammation","volume":"50","author":"Gao","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00011-013-0625-0","article-title":"Interleukin-1\u03b2 induces a reversible cardiomyopathy in the mouse","volume":"62","author":"Seropian","year":"2013","journal-title":"Inflamm. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1677\/JOE-06-0047","article-title":"Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization","volume":"192","author":"Simons","year":"2007","journal-title":"J. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.gendis.2022.10.018","article-title":"Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges","volume":"10","author":"Lei","year":"2023","journal-title":"Genes Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00395-013-0329-1","article-title":"Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1\u03b1 signaling contributing to increased vulnerability in diabetic heart","volume":"108","author":"Yan","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"950","DOI":"10.5551\/jat.31740","article-title":"Endothelial and Metabolic Function Interactions in Overweight\/Obese Children","volume":"23","author":"Ciccone","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"153252","DOI":"10.1016\/j.tox.2022.153252","article-title":"MicroRNA-223\u20133p promotes pyroptosis of cardiomyocyte and release of inflammasome factors via downregulating the expression level of SPI1 (PU. 1)","volume":"476","author":"Zhao","year":"2022","journal-title":"Toxicology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.ajpath.2017.08.023","article-title":"Aggravated postinfarct heart failure in type 2 diabetes is associated with impaired mitophagy and exaggerated inflammasome activation","volume":"187","author":"Devi","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2020.11.004","article-title":"Diabetes changes gene expression but not DNA methylation in cardiac cells","volume":"151","author":"Lother","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kesherwani, V., Shahshahan, H.R., and Mishra, P.K. (2017). Cardiac transcriptome profiling of diabetic Akita mice using microarray and next generation sequencing. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182828"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Henson, S.M., and Aksentijevic, D. (2021). Senescence and type 2 diabetic cardiomyopathy: How young can you die of old age?. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.716517"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart Failure in Type 2 Diabetes Mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2337\/db06-S002","article-title":"Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction","volume":"55","author":"Morino","year":"2006","journal-title":"Diabetes"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4093\/dmj.2019.0185","article-title":"Mitochondrial mechanisms in diabetic cardiomyopathy","volume":"44","author":"Gollmer","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Dabravolski, S.A., Sadykhov, N.K., Kartuesov, A.G., Borisov, E.E., Sukhorukov, V.N., and Orekhov, A.N. (2022). The role of mitochondrial abnormalities in diabetic cardiomyopathy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147863"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/bph.15068","article-title":"The role of mitochondrial dynamics in cardiovascular diseases","volume":"178","author":"Forte","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3960773","DOI":"10.1155\/2021\/3960773","article-title":"Mitochondrial quality control in the maintenance of cardiovascular homeostasis: The roles and interregulation of UPS, mitochondrial dynamics and mitophagy","volume":"2021","author":"Song","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41420-022-01046-w","article-title":"Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice","volume":"8","author":"Yan","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0022-2828(92)93381-S","article-title":"Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man","volume":"24","author":"Barth","year":"1992","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_44","unstructured":"Opie, L.H. (2004). Heart Physiology: From Cell to Circulation, Lippincott Williams Wilkins."},{"key":"ref_45","first-page":"456","article-title":"Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET","volume":"36","author":"Ohtake","year":"1995","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1113\/JP276747","article-title":"Cardiomyopathy in obesity, insulin resistance and diabetes","volume":"598","author":"Nakamura","year":"2020","journal-title":"J. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1050-1738(00)00077-3","article-title":"PPAR signaling in the control of cardiac energy metabolism","volume":"10","author":"Barger","year":"2000","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPAR\u03b1 overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_49","first-page":"1555","article-title":"Lipotoxicity in obesity and diabetes-related cardiac dysfunctioniochim","volume":"1861","author":"Zlobine","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Biol. Lipids"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"E897","DOI":"10.1152\/ajpendo.00509.2009","article-title":"Shedding light on the enigma of myocardial lipotoxicity: The involvement of known and putative regulators of fatty acid storage and mobilization","volume":"298","author":"Brindley","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/joim.12728","article-title":"Manifestations and mechanisms of myocardial lipotoxicity in obesity","volume":"284","author":"Sletten","year":"2018","journal-title":"J. Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12997\/jla.2019.8.1.26","article-title":"Established and Emerging Mechanisms of Diabetic Cardiomyopathy","volume":"8","author":"Gollmer","year":"2019","journal-title":"J. Lipid Atheroscler."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacbts.2018.04.005","article-title":"Fatty Acids Prevent Hypoxia-Inducible Factor-1\u03b1 Signaling through Decreased Succinate in Diabetes","volume":"3","author":"Dodd","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1139\/cjpp-2014-0544","article-title":"Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes","volume":"93","author":"Sturza","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.lfs.2016.08.030","article-title":"Garlic activates SIRT-3 to prevent cardiac oxidative stress and mitochondrial dysfunction in diabetes","volume":"164","author":"Sultana","year":"2016","journal-title":"Life Sci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Cater, M., and Krizancic Bombek, L. (2022). Protective Role of Mitochondrial Uncoupling Proteins against Age-Related Oxidative Stress in Type 2 Diabetes Mellitus. Antioxidants, 11.","DOI":"10.3390\/antiox11081473"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Spinelli, S., Guida, L., Passalacqua, M., Magnone, M., Cossu, V., Sambuceti, G., Marini, C., Sturla, L., and Zocchi, E. (2023). Abscisic Acid and Its Receptors LANCL1 and LANCL2 Control Cardiomyocyte Mitochondrial Function, Expression of Contractile, Cytoskeletal and Ion Channel Proteins and Cell Proliferation via ERRalpha. Antioxidants, 12.","DOI":"10.20944\/preprints202308.0328.v1"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00424-009-0729-0","article-title":"The role of mitochondrial uncoupling proteins in lifespan","volume":"459","author":"Dietrich","year":"2010","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbadis.2016.08.021","article-title":"Mitochondrial dysfunction and its impact on diabetic heart","volume":"1863","author":"Verma","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Bai, J., Liu, C., Zhu, P., and Li, Y. (2020). Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.609157"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Mohan, M., Dihoum, A., Mordi, I.R., Choy, A.M., Rena, G., and Lang, C.C. (2021). Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.746382"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pan, K.L., Hsu, Y.C., Chang, S.T., Chung, C.M., and Lin, C.L. (2023). The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108604"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"R1481","DOI":"10.1152\/ajpregu.00232.2003","article-title":"Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes","volume":"285","author":"Sundgren","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cphy.c160021","article-title":"Pathophysiological Fundamentals of Diabetic Cardiomyopathy","volume":"7","author":"Hu","year":"2017","journal-title":"Compr. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Cairns, M., Joseph, D., and Essop, M.F. (2022). The dual role of the hexosamine biosynthetic pathway in cardiac physiology and pathophysiology. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.984342"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1152\/physrev.00043.2019","article-title":"Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology","volume":"101","author":"Chatham","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"26515","DOI":"10.1074\/jbc.M116.754481","article-title":"O-GlcNAcylation of 8-Oxoguanine DNA Glycosylase (Ogg1) Impairs Oxidative Mitochondrial DNA Lesion Repair in Diabetic Hearts","volume":"291","author":"Cividini","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1073\/pnas.1424017112","article-title":"Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria","volume":"112","author":"Banerjee","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00726-010-0699-8","article-title":"Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice","volume":"40","author":"Marsh","year":"2011","journal-title":"Amino Acids"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e014046","DOI":"10.1161\/JAHA.119.014046","article-title":"O-GlcNAcylation Mediates Glucose-Induced Alterations in Endothelial Cell Phenotype in Human Diabetes Mellitus","volume":"9","author":"Masaki","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2019.02.036","article-title":"Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling","volume":"222","author":"Cui","year":"2019","journal-title":"Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Karimi, M., Pavlov, V.I., Ziegler, O., Sriram, N., Yoon, S.Y., Agbortoko, V., Alexandrova, S., Asara, J., Sellke, F.W., and Sturek, M. (2019). Robust effect of metabolic syndrome on major metabolic pathways in the myocardium. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225857"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/cvr\/cvz216","article-title":"Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes","volume":"116","author":"Si","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.freeradbiomed.2021.02.040","article-title":"Oxidative stress in cardiac hypertrophy: From molecular mechanisms to novel therapeutic targets","volume":"166","author":"Ramachandra","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.119.14400","article-title":"DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway","volume":"75","author":"Okabe","year":"2020","journal-title":"Hypertension"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NFkappaB signaling pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/db06-1163","article-title":"Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: The role of angiotensin type 1 receptor antagonism","volume":"56","author":"Westermann","year":"2007","journal-title":"Diabetes"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/HYPERTENSIONAHA.115.06015","article-title":"Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females","volume":"66","author":"Jia","year":"2015","journal-title":"Hypertension"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/db08-0805","article-title":"Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis","volume":"57","author":"Singh","year":"2008","journal-title":"Diabetes"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1253\/circj.CJ-13-1564","article-title":"Diabetes-related heart failure","volume":"78","author":"Bando","year":"2014","journal-title":"Circ. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI117004","article-title":"Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta","volume":"93","author":"Ziyadeh","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"H1675","DOI":"10.1152\/ajpheart.91493.2007","article-title":"Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: Role in extracellular matrix production","volume":"294","author":"Singh","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Tuleta, I., and Frangogiannis, N.G. (2021). Diabetic fibrosis. Biochim. Biophys. Acta Mol. Basis Dis., 1867.","DOI":"10.1016\/j.bbadis.2020.166044"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/labinvest.3780057","article-title":"Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II\u2014Dependent","volume":"80","author":"Fiordaliso","year":"2000","journal-title":"Lab. Investig."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2019.12.051","article-title":"Hyperglycemia-induced cardiomyocyte death is mediated by lysosomal membrane injury and aberrant expression of cathepsin D","volume":"523","author":"Kobayashi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00109-011-0816-5","article-title":"The imbalance of Th17\/Th1\/Tregs in patients with type 2 diabetes: Relationship with metabolic factors and complications","volume":"90","author":"Zeng","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Filardi, T., Ghinassi, B., Di Baldassarre, A., Tanzilli, G., Morano, S., Lenzi, A., Basili, S., and Crescioli, C. (2019). Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133299"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1677\/JOE-06-0081","article-title":"Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1\/2","volume":"193","author":"Lappas","year":"2007","journal-title":"J. Endocrinol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10741-016-9536-9","article-title":"The fibrosis-cell death axis in heart failure","volume":"21","author":"Piek","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","article-title":"Mechanisms of altered Ca2\u207a handling in heart failure","volume":"113","author":"Luo","year":"2013","journal-title":"Circ. Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Dattani, A., Singh, A., McCann, G.P., and Gulsin, G.S. (2023). Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.3390\/jcdd11010012"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCRESAHA.109.199810","article-title":"Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy","volume":"105","author":"Kemi","year":"2009","journal-title":"Circ. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/2211-5463.12284","article-title":"Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide","volume":"7","author":"Hegab","year":"2017","journal-title":"FEBS Open Bio"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2020.03.016","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGF\u03b2 signaling in type 2 diabetes mellitus","volume":"142","author":"Tang","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/jdi.13451","article-title":"Calcium signaling in endocardial and epicardial ventricular myocytes from streptozotocin-induced diabetic rats","volume":"12","author":"Sydorenko","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1113\/EP086412","article-title":"Arrhythmogenic gene remodelling in elderly patients with type 2 diabetes with aortic stenosis and normal left ventricular ejection fraction","volume":"102","author":"Ashrafi","year":"2017","journal-title":"Exp. Physiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-5223(99)70233-3","article-title":"The structure and function of the cardiac myocyte: A review of fundamental concepts","volume":"118","author":"Walker","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2337\/diabetes.52.7.1825","article-title":"Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors\/calcium-release channels","volume":"52","author":"Bidasee","year":"2003","journal-title":"Diabetes"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"26492","DOI":"10.1016\/S0021-9258(18)47221-3","article-title":"Identification of Ser38 as the site in cardiac sarcoplasmic reticulum Ca(2+)-ATPase that is phosphorylated by Ca2+\/calmodulin-dependent protein kinase","volume":"269","author":"Toyofuku","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diabetes.53.2.463","article-title":"Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase","volume":"53","author":"Bidasee","year":"2004","journal-title":"Diabetes"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/emm.2016.7","article-title":"Recent progress in genetic and epigenetic research on type 2 diabetes","volume":"48","author":"Kwak","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.2337\/db09-1003","article-title":"Epigenetics: A molecular link between environmental factors and type 2 diabetes","volume":"58","author":"Ling","year":"2009","journal-title":"Diabetes"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Khullar, M., Cheema, B.S., and Raut, S.K. (2017). Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes. Front. Endocrinol., 8.","DOI":"10.3389\/fendo.2017.00237"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1753944717704590","article-title":"DUSP-1 gene expression is not regulated by promoter methylation in diabetes-associated cardiac hypertrophy","volume":"11","author":"Singh","year":"2017","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Suo, W., Zhang, X., Yang, Y., Zhao, W., Li, H., and Ni, Q. (2023). Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids. Biomed. Pharmacother., 157.","DOI":"10.1016\/j.biopha.2022.114025"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7150\/ijbs.11218","article-title":"DNA methylation, its mediators and genome integrity","volume":"11","author":"Meng","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1080\/21691401.2019.1617724","article-title":"DNA methylation abnormalities in atherosclerosis","volume":"47","author":"Tabaei","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Santos, J.L., Krause, B.J., Cataldo, L.R., Vega, J., Salas-P\u00e9rez, F., Mennickent, P., Gallegos, R., Milagro, F.I., Prieto-Hontoria, P., and Riezu-Boj, J.I. (2020). PPARGC1A Gene Promoter Methylation as a Biomarker of Insulin Secretion and Sensitivity in Response to Glucose Challenges. Nutrients, 12.","DOI":"10.3390\/nu12092790"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/CCM.0b013e3181b4a854","article-title":"Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes","volume":"38","author":"Kao","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000258855.60637.58","article-title":"Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension","volume":"100","author":"Bogdarina","year":"2007","journal-title":"Circ. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2018.08.032","article-title":"Histone Modifications: Insights into Their Influence on Gene Expression","volume":"175","author":"Stillman","year":"2018","journal-title":"Cell"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2019.01.015","article-title":"HDAC inhibitors and cardioprotection: Homing in on a mechanism of action","volume":"40","author":"Weeks","year":"2019","journal-title":"eBioMedicine"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/ATVBAHA.108.179150","article-title":"Role of Src tyrosine kinase in the atherogenic effects of the 12\/15-lipoxygenase pathway in vascular smooth muscle cells","volume":"29","author":"Reddy","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"E1119","DOI":"10.1152\/ajpendo.00029.2008","article-title":"Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level","volume":"294","author":"Feng","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/ijpo.12439","article-title":"Pilot study on circulating miRNA signature in children with obesity born small for gestational age and appropriate for gestational age","volume":"13","author":"Marzano","year":"2018","journal-title":"Pediatr. Obes."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/eurheartj\/ehv599","article-title":"MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart","volume":"37","author":"Costantino","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.bbadis.2017.03.013","article-title":"Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention","volume":"1863","author":"Guo","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"143995","DOI":"10.1016\/j.gene.2019.143995","article-title":"Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K\/Akt signaling pathway via PIK3CA","volume":"715","author":"Yang","year":"2019","journal-title":"Gene"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ijlh.12426","article-title":"Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: Analysis of results obtained in the DULCIS study","volume":"38","author":"Palareti","year":"2016","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.carpath.2015.06.003","article-title":"Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice","volume":"24","author":"Yu","year":"2015","journal-title":"Cardiovasc. Pathol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.lfs.2019.02.059","article-title":"MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart","volume":"224","author":"Liang","year":"2019","journal-title":"Life Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/dmrr.2514","article-title":"Physical exercise as therapy for type 2 diabetes mellitus","volume":"30","author":"Balducci","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.omtn.2020.11.007","article-title":"Adeno-associated virus-mediated delivery of anti-miR-199a tough decoys attenuates cardiac hypertrophy by targeting PGC-1alpha","volume":"23","author":"Yan","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bbrc.2008.09.025","article-title":"Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1","volume":"376","author":"Yu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1080\/15384101.2020.1831245","article-title":"LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p\/AHR","volume":"19","author":"Xu","year":"2020","journal-title":"Cell Cycle"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11010-016-2729-7","article-title":"miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy","volume":"417","author":"Raut","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00125-015-3622-8","article-title":"Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL\/6 mice","volume":"58","author":"Zheng","year":"2015","journal-title":"Diabetologia"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","article-title":"MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway","volume":"116","author":"Kuwabara","year":"2015","journal-title":"Circ. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.3390\/ijms140917319","article-title":"Oxidative stress and microRNAs in vascular diseases","volume":"14","author":"Magenta","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10495-020-01609-1","article-title":"Upregulation of microRNA-532 enhances cardiomyocyte apoptosis in the diabetic heart","volume":"25","author":"Chandrasekera","year":"2020","journal-title":"Apoptosis"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.peptides.2016.02.007","article-title":"Glucagon-like peptide-1 regulates calcium homeostasis and electrophysiological activities of HL-1 cardiomyocytes","volume":"78","author":"Huang","year":"2016","journal-title":"Peptides"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/jc.2014-2291","article-title":"Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: A prospective pilot study","volume":"100","author":"Rizzo","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.3892\/mmr.2020.11599","article-title":"Metformin protects high glucose-cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK signaling pathway","volume":"22","author":"Liu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2961954","DOI":"10.1155\/2016\/2961954","article-title":"Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia\/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK","volume":"2016","author":"Hu","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1111\/jcmm.14834","article-title":"Metformin upregulates mitophagy in patients with T2DM: A randomized placebo-controlled study","volume":"24","author":"Bhansali","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Dia, M., Leon, C., Chanon, S., Bendridi, N., Gomez, L., Rieusset, J., Thibault, H., and Paillard, M. (2022). Effect of Metformin on T2D-Induced MAM Ca(2+) Uncoupling and Contractile Dysfunction in an Early Mouse Model of Diabetic HFpEF. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073569"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Jia, Y., Li, D., Yu, J., Jiang, W., Liao, X., and Zhao, Q. (2022). Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.985020"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lfs.2016.03.049","article-title":"Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a\/NCX1 pathway","volume":"153","author":"Akhtar","year":"2016","journal-title":"Life Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/cvr\/cvab123","article-title":"SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy","volume":"118","author":"Torre","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12933-015-0262-8","article-title":"Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice","volume":"14","author":"Chen","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1042\/CS20170064","article-title":"Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1\/2 pathway","volume":"131","author":"Xu","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(21)00292-8","article-title":"Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): A post-hoc analysis of a randomised, double-blind trial","volume":"10","author":"Verma","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.121.056824","article-title":"Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial","volume":"144","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3\/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/jphp.12223","article-title":"Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats","volume":"66","author":"Tahara","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Lee, T.I., Chen, Y.C., Lin, Y.K., Chung, C.C., Lu, Y.Y., Kao, Y.H., and Chen, Y.J. (2019). Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071680"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2174\/1570161118666191217123930","article-title":"Uric Acid in Metabolic and Cerebrovascular Disorders: A Review","volume":"18","author":"Cortese","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"106565","DOI":"10.1016\/j.vph.2019.106565","article-title":"Uric acid: From a biological advantage to a potential danger. A focus on cardiovascular effects","volume":"120","author":"Cortese","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/cvr\/cvu045","article-title":"Epicardial adipose tissue and atrial fibrillation","volume":"102","author":"Hatem","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1002\/ehf2.13645","article-title":"SGLT2 inhibitors and cardiac remodelling: A systematic review and meta-analysis of randomized cardiac magnetic resonance imaging trials","volume":"8","author":"Dhingra","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cjca.2019.08.033","article-title":"Direct Effects of Empagliflozin on Extracellular Matrix Remodelling in Human Cardiac Myofibroblasts: Novel Translational Clues to Explain EMPA-REG OUTCOME Results","volume":"36","author":"Kang","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"CV Protection in the EMPA-REG OUTCOME Trial: A \u201cThrifty Substrate\u201d Hypothesis","volume":"39","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_162","first-page":"533","article-title":"Altered systemic ketone body metabolism in advanced heart failure","volume":"38","author":"Janardhan","year":"2011","journal-title":"Tex. Heart Inst. J."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/dc16-0542","article-title":"Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis","volume":"39","author":"Mudaliar","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cmet.2016.07.018","article-title":"Empagliflozin\u2019s Fuel Hypothesis: Not so Soon","volume":"24","author":"Lopaschuk","year":"2016","journal-title":"Cell Metab."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncomms2090","article-title":"The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy","volume":"3","author":"Ucar","year":"2012","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8280\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:25:59Z","timestamp":1760109959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":165,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25158280"],"URL":"https:\/\/doi.org\/10.3390\/ijms25158280","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]}}}